Sinclair Lab Research ·
Research indicates that SIRT2 plays a crucial role in lifespan extension by regulating the checkpoint kinase BubR1. This study highlights the connection between SIRT2, NAD+ levels, and the aging process, particularly focusing on the implications for healthspan. Understanding these mechanisms is vital for developing interventions that may delay age-related diseases.
What this study examined
This study investigated the role of the mitotic checkpoint kinase BubR1 in lifespan regulation using mouse models. Mice that overexpressed BubR1 demonstrated increased longevity, while mice with reduced BubR1 levels exhibited accelerated aging. The research focused on the decline of BubR1 with age and its relationship to NAD+ levels and SIRT2 activity. The primary outcome was the effect of SIRT2 overexpression and NAD+ precursor treatment on BubR1 levels and median lifespan in these models.
Why this matters for longevity research
The findings from this study are significant for longevity research as they elucidate a mechanism by which SIRT2 and NAD+ can influence aging. As BubR1 levels decline with age, understanding how to maintain or restore these levels could provide insights into delaying age-related diseases. This research aligns with the broader context of the information theory of aging, which posits that maintaining cellular information integrity is crucial for longevity.
Key findings
- Mice overexpressing BubR1 exhibited increased lifespan.
- BubR1 hypomorphic mice showed signs of accelerated aging and reduced lifespan.
- As wild-type mice age, BubR1 levels decline in various tissues.
- The decline in BubR1 is linked to decreased NAD+ levels.
- SIRT2 maintains BubR1 in a deacetylated state, counteracting the effects of acetyltransferase CBP.
- Overexpression of SIRT2 or treatment with nicotinamide mononucleotide (NMN) increased BubR1 abundance.
- In BubR1(H/H) mice, SIRT2 overexpression significantly increased median lifespan, especially in males.
The science behind it
This research contributes to the understanding of the NAD+/sirtuin axis, where sirtuins, including SIRT2, are NAD+-dependent deacetylases that play a role in cellular metabolism and aging. The decline in NAD+ levels with age is a critical factor in the aging process, affecting various cellular functions. SIRT2's ability to deacetylate BubR1 at lysine-668 is a key mechanism through which it influences lifespan. This relationship highlights the importance of maintaining NAD+ levels to potentially counteract aging and promote longevity.
How it fits into the longevity field
This study fits within the broader landscape of aging research, particularly in the context of interventions aimed at extending healthspan and lifespan. Other interventions, such as caloric restriction and exercise, also influence sirtuin activity and NAD+ levels. The findings underscore the potential for targeting the sirtuin pathway as a therapeutic strategy for age-related diseases, complementing existing research on epigenetic reprogramming and cellular rejuvenation.
Practical takeaways
Researchers and informed readers should note the importance of maintaining NAD+ levels and exploring the role of sirtuins in aging. The findings suggest that interventions aiming to enhance SIRT2 activity or increase NAD+ availability could be promising avenues for future research. While these results are based on animal models, they provide a foundation for understanding potential therapeutic strategies in humans.
FAQ
How does SIRT2 influence aging?
SIRT2 influences aging by regulating the checkpoint kinase BubR1, which is essential for maintaining cellular health as organisms age.
What role does NAD+ play in longevity?
NAD+ is crucial for the activity of sirtuins, including SIRT2, and its levels decline with age, impacting various cellular processes related to aging.
Can increasing BubR1 levels extend lifespan?
Yes, studies show that overexpressing BubR1 can lead to increased lifespan, indicating its importance in longevity research.
Source: PubMed · EMBO J · published 2014-07-01.